SREBF1 and renal cell carcinoma: Our data suggest that the coordinated metabolic shift via the PRCC‐TFE3/HIF1α/SREBP1 axis is a key mechanism by which PRCC‐TFE3 enhances cancer cell metabolism, promoting tumor development in TFE3‐RCC.